University of Lorraine, UMR INSERM U.1122 "IGE-PCV", Nancy, France.
Pharmacogenomics. 2014 Apr;15(5):593-9. doi: 10.2217/pgs.14.35.
The second international European Society of Pharmacogenomics and Theranostics (ESPT) conference was organized in Lisbon, Portugal, and attracted 250 participants from 37 different countries. The participants could listen to 50 oral presentations, participate in five lunch symposia and were able to view 83 posters and an exhibition. The first part of this Conference Scene will focus on the pharmacogenomics and biomarkers used in medical oncology, and in particular solid tumors. In addition, this article covers the two keynote conference introductory lectures by Ann K Daly and Magnus Ingelman-Sundberg. The second part of this article will discuss the clinical implementation of pharmacogenomic tests; the role of transports and pharmacogenomics; how stem cells and other new tools are helping the development of pharmacogenomics and drug discovery; and an update on the clinical translation of pharmacogenomics to personalized medicine. Part two of this Conference Scene will be featured in the next issue of Pharmacogenomics.
第二届国际欧洲药物基因组学和治疗学学会（ESPT）会议在葡萄牙里斯本举行，吸引了来自 37 个不同国家的 250 名参与者。与会者可以听取 50 个口头报告，参加 5 个午餐座谈会，并观看 83 个海报和一个展览。本会议现场的第一部分将重点介绍医学肿瘤学，特别是实体肿瘤中使用的药物基因组学和生物标志物。此外，本文还涵盖了 Ann K Daly 和 Magnus Ingelman-Sundberg 的两个主题演讲。本文的第二部分将讨论药物基因组学检测的临床实施；转运蛋白和药物基因组学的作用；干细胞和其他新工具如何帮助药物基因组学和药物发现的发展；以及药物基因组学向个体化医学的临床转化的最新进展。本会议现场的第二部分将在下一期《药物基因组学》中重点介绍。
